Literature DB >> 33999911

The Use of Computer Navigation and Robotic Technology in Complex Total Knee Arthroplasty.

Keir A Ross1, Daniel H Wiznia2, William J Long1, Ran Schwarzkopf1.   

Abstract

»: The potential benefits of computer-assisted surgical (CAS) navigation and robotic total knee arthroplasty (TKA) systems, such as increased reliability of restoring the mechanical axis, fewer outliers, more rapid hospital discharge, less physical therapy requirements, decreased blood loss, and decreased revision rates, have led to their application not only in primary cases but also in complex cases such as preoperative deformity and revision. »: Early evidence demonstrates that CAS navigation may help to improve alignment in complex cases of femoral and tibial deformity and in cases of femoral bowing. »: Data regarding deformity correction with robotic systems are similar to CAS navigation with regard to alignment, but are more limited. There are also scant data regarding revision cases and cases of previous intramedullary canal instrumentation. »: Concerns remain regarding cost, learning curves, and operative times. There are potential long-term cost savings associated with a decrease in revisions and readmissions that require additional investigation. »: Early evidence for the use of these emerging technologies for deformity correction and revision cases is promising, but their impact on long-term functional outcomes remains to be demonstrated. Additional well-designed comparative studies are warranted.
Copyright © 2021 by The Journal of Bone and Joint Surgery, Incorporated.

Entities:  

Mesh:

Year:  2021        PMID: 33999911     DOI: 10.2106/JBJS.RVW.20.00200

Source DB:  PubMed          Journal:  JBJS Rev        ISSN: 2329-9185


  1 in total

1.  Robotic-assisted TKA reduces surgery duration, length of stay and 90-day complication rate of complex TKA to the level of noncomplex TKA.

Authors:  Ricarda Stauss; Peter Savov; Lars-René Tuecking; Henning Windhagen; Max Ettinger
Journal:  Arch Orthop Trauma Surg       Date:  2022-10-14       Impact factor: 2.928

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.